Sign In
Skip navigation links
HOME
ABOUT US
RESEARCHERS
PATIENT CARE
PUBLICATIONS
CHRU TeamsExpand CHRU Teams
FacilitiesExpand Facilities
PartnersExpand Partners
Donors
NewsExpand News
Scroll up
Scroll down
Meet the Leadership
Senior Management Team
Scroll up
Scroll down
RightMed Pharmacy
Scroll up
Scroll down
International Collaboration
About Wits Health Consortium
HEERO
Right to Care
WRHI
Scroll up
Scroll down
Themba Lethu Clinic Celebrates 20 Years
NIAID Officials visits CHRU
New Study Discovers Unique HIV Feature
Scroll up
Scroll down
Prof Patrick MacPhail
Dr Sharlaa Badal-Faesen
Dr Eefje Jong
Dr Karla Mellet
Dr Mohammed Rassool
Dr Noluthando Mwelase
Scroll up
Scroll down
Clinical trial volunteers
The Community Advisory Board (CAB)
Scroll up
Scroll down
High Impact
Scroll up
Scroll down
OGAC NIAID NIH NIAID

Prof Ian Sanne Hosts Members of OGAC

The PEPFAR implementation team, at the TB Focal Point of the Themba Lethu Clinic at the Helen Joseph Academic Hospital

Dr Anthony Fauci

Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH, US is welcomed by members of the CHRU Choir

South African Scientists Brainstorm

NIH Clinical Research Networks for HIV/AIDS and Other Infectious Diseases Grantsmanship Workshop, October 2012

Members of the Delegation of the National Institute of Health’s National Allergy and Infectious Diseases (NIAID) visit CHRU

From left F. Gray Handley, NIAID Associate Director for International Research Affairs, Hugh Auchincloss, (NIAID Deputy Director) and Anthony S. Fauci (NIAID Director).

Who We Are

Map Of Africa
The CHRU is a successful, internationally recognised research and training unit, which is substantially funded by the National Institutes of Health (NIH) and USAID/PEPFAR-funded. More

News

  • Dr Toni Fauci, NIAID Director and his Deputy Director Dr Hugh Auchincloss enjoys the CHRU choir’s welcome song HIV/AIDS in South Africa
  • Themba Lethu Clinic Celebrates 20 Years
  • New Study Discovers Unique HIV Feature

Recent Publications

  • ART Administration and Monitor

    Nurse management is not inferior to doctor management of antiretroviral patients
  • Prevention of HIV-1 Infection with Early ART

    The early initiation of ART reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy
  • Timing of ART for HIV-1 Infection and Tuberculosis

    CD4+ T-cell counts < 50 mm³ & Earlier ART reduce the rate of new AIDS-defining illness and death.
More
  1. Contact Us
  2. Links
  3. Photo Gallery